DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Kronox Lab Sciences Limited — Disclosure under SEBI Takeover Regulations

NSE 2 hrs ago·29 Sept 2026, 11:43 am

Kronox LAB Sciences

Kronox Lab Sciences Limited has disclosed that Indo Borax & Chemicals Ltd has submitted a formal disclosure under SEBI's Takeover Regulations. This regulatory filing is a mandatory requirement for any entity acquiring a significant stake in a listed company.

For investors, this disclosure signals that Indo Borax is building a substantial position in Kronox. Such moves often hint at potential strategic intent, such as a future takeover, merger, or a significant long-term investment in the company's operations.

Investors should now monitor the exchange filings for further updates. It is crucial to wait for official announcements regarding the exact percentage of shares acquired and the specific purpose behind this investment before drawing any conclusions.